Headquartered in Redmond, Washington, USA, Inventprise is a biotechnology company specializing in GMP vaccine product development. Inventprise has a strong portfolio of patented technologies for conjugation chemistry and product stability, among others. We also undertake contract development, research and manufacturing. Inventprise was founded in 2012 by Dr. Subhash Kapre, whose five decades of executive experience in the vaccine field covered all aspects of development and manufacturing.

Inventprise has grown at a rapid pace, from a startup in downtown Seattle to a global company with development and manufacturing locations in several countries.

Our focus is on stable, low-cost solutions with real-world applications. We strive for rapid progress from development to product approval to scalable manufacturing and efficient worldwide distribution. Our team of world-class scientists and engineers have decades of experience with all stages of this process.

We’re grateful to the Bill & Melinda Gates Foundation for supporting much of our work.